Carbamazepine

Where the papers sit

10 papers from the last 6 months study carbamazepine directly · updated from PubMed 12 Oct 2026

• Predictive Drug Formulation

  Drug formulation is moving from empirical tablet development toward predictive control of compaction, flow, sticking, and dissolution. Carbamazepine serves as a test case for solid-form impurity, modified-release performance, and dissolution methods, while other work examines pediatric 3D-printed and hydroethanolic-release systems. Design-of-experiments and flow-through-cell testing aim to connect material properties with release behavior. The remaining challenge is translating these models across drugs, excipients, and dosage forms.

  5 papers · 50%

• Antiseizure Medication Safety

  Safety assessment is linking HLA risk alleles and systemic hypersensitivity with psychiatric outcomes during antiseizure treatment. HLA-B15:21 may identify cutaneous reaction risk even in HLA-B15:02-negative patients, while carbamazepine-induced hypersensitivity can involve primary adrenal insufficiency. Cohort data also examine anxiety and other psychiatric effects across antiseizure medications. The shared direction is toward individualized selection and closer monitoring, although the evidence spans rare case reports and observational outcomes.

  3 papers · 30%

• Neural Homeostasis in Seizures

  Preclinical seizure research is focusing on preserving and visualizing ionic and redox homeostasis in the brain. Carbamazepine preserves systemic sodium balance and hippocampal Atp1a1 expression after pentylenetetrazol-induced seizures. Brain-permeable near-infrared probes extend this work by tracking H2S dynamics during neurological stress. Together, the studies support homeostatic disruption as both a treatment target and a measurable biomarker, but clinical relevance remains open.

  2 papers · 20%